MedPath

ZEMPLAR

ZEMPLAR

Discontinued
DIN Number

02266202

Drug Class

Human

Market Date

Dec 1, 2005

Company
HC

Abbvie Corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02266202
AIG Number0150742001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
H05BX02 PARICALCITOL
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification88:16.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

PARICALCITOLActive
Strength: 5 MCG / ML
Monograph: PARICALCITOL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.